Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Spectral Medical Inc
T.EDT
Alternate Symbol(s):
EDTXF
Healthcare
Diagnostics & Research
Medical Instruments & Supplies
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion...
device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSX:EDT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(88)
•••
Stocktree
X
Post by
Stocktree
on Aug 12, 2025 10:56am
Top line results hyping...
Yeah, I don't think Spectral's announcement will be in the form of a benefit percetage. They will likely publish some bayesian math and emit a statement on the lines of "We expect the FDA
...more
(467)
•••
mercedesman
X
Comment by
mercedesman
on Aug 11, 2025 6:54pm
RE:I don't care what valuation you put and why,
I am personally looking forward to suffering the slings and arrows of an outrageous fortune, as might be achieved by 14 or 15 and > 95% It's all over but the waiting. Bought more in
...more
(284)
•••
BlueJays9293
X
Post by
BlueJays9293
on Aug 11, 2025 5:36pm
I don't care what valuation you put and why,
but every serious Spectral shareholder should be mentally putting together what their individual valuation beliefs are, based on the various scenarios of the Top Line numbers. Once those numbers
...more
(88)
•••
Stocktree
X
Comment by
Stocktree
on Aug 11, 2025 9:12am
RE:RE:RE:RE:RE:RE:4 things we ain't seeing on this BB anymore by PPs
Yes.
(109)
•••
oilandgasman
X
Comment by
oilandgasman
on Aug 10, 2025 11:30am
RE:RE:RE:RE:RE:4 things we ain't seeing on this BB anymore by PPs
I think you make some good points, it's been years long pumping by some. By any chance were you invested in Spectral during the 2016 crash?
(636)
•••
TechOne
X
Post by
TechOne
on Aug 09, 2025 2:01am
FDA Grants Spectral Medical Breakthrough Device Designation
US FDA Grants Spectral Medical Breakthrough Device Designation for Toraymyxin™ (“PMX”) for the Treatment of Endotoxemic Septic Shock Jul 11, 2022
...more
(636)
•••
TechOne
X
Post by
TechOne
on Aug 09, 2025 1:58am
Breakthrough Device Designation and PMA Process
Breakthrough Device Designation, within the FDA's Premarket Approval (PMA) process, is a program designed to expedite the development, assessment, and review of medical devices that
...more
(188)
•••
Spamme54321
X
Comment by
Spamme54321
on Aug 08, 2025 7:04pm
RE:RE:RE:RE:RE:4 things we ain't seeing on this BB anymore by PPs
Yeah Mercedes was one of the chief pumpers here. Suddenly gone silent. He probably finished selling his shares so no need to keep pumping.
(284)
•••
BlueJays9293
X
Comment by
BlueJays9293
on Aug 08, 2025 6:20pm
RE:THIS WEEKS NUMBERS
Thanks Rev. We got a new data point today and also confirmation of a previously reported data point. "Data lock completed at end of July 2025" We also saw in today's MD&A, a
...more
(352)
•••
hmmmmmmmm
X
Post by
hmmmmmmmm
on Aug 08, 2025 6:00pm
Calling balls and strikes
The quote from Spectral's post today is the most bullish statement we've seen from management since the "exceeding expectations" era. Remember- the trial data has been locked since
...more
(88)
•••
Stocktree
X
Comment by
Stocktree
on Aug 08, 2025 4:59pm
RE:RE:RE:RE:4 things we ain't seeing on this BB anymore by PPs
You are being completely disingenuous with this kind of reply. Stay on point. 1- I noted the chief pumpers are not pumping 2- You attacked me for staying years on this board with "negative"
...more
(74)
•••
Geery
X
Comment by
Geery
on Aug 08, 2025 4:38pm
RE:RE:RE:4 things we ain't seeing on this BB anymore by PPs
Think I highlighted some pros/cons and thoughts of success earleir this week.
(88)
•••
Stocktree
X
Comment by
Stocktree
on Aug 08, 2025 4:33pm
RE:RE:4 things we ain't seeing on this BB anymore by PPs
There is a s**t ton of difference between a normal investor/poster, who would be hoping for success and explaning their optimism - but also regularly voicing their concerns and worries and
...more
(221)
•••
Revten
X
Post by
Revten
on Aug 08, 2025 4:26pm
THIS WEEKS NUMBERS
House Positions for C:EDT from 20250804 to 20250808 House Bought $Val Ave Sold $Val Ave Net $Net
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Building Momentum in One of the World's Most Prospective Copper Regions
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)
A Company Focused on Developing Functional Healthier “Better For You” Foods